255 related articles for article (PubMed ID: 29146590)
1. CaMKIIα Mediates the Effect of IL-17 To Promote Ongoing Spontaneous and Evoked Pain in Multiple Sclerosis.
Hu X; Huang F; Wang ZJ
J Neurosci; 2018 Jan; 38(1):232-244. PubMed ID: 29146590
[TBL] [Abstract][Full Text] [Related]
2. Ca2+/calmodulin-dependent protein kinase II alpha is required for the initiation and maintenance of opioid-induced hyperalgesia.
Chen Y; Yang C; Wang ZJ
J Neurosci; 2010 Jan; 30(1):38-46. PubMed ID: 20053885
[TBL] [Abstract][Full Text] [Related]
3. CaMKIIα underlies spontaneous and evoked pain behaviors in Berkeley sickle cell transgenic mice.
He Y; Chen Y; Tian X; Yang C; Lu J; Xiao C; DeSimone J; Wilkie DJ; Molokie RE; Wang ZJ
Pain; 2016 Dec; 157(12):2798-2806. PubMed ID: 27842048
[TBL] [Abstract][Full Text] [Related]
4. Regulatory T Cells and Their Derived Cytokine, Interleukin-35, Reduce Pain in Experimental Autoimmune Encephalomyelitis.
Duffy SS; Keating BA; Perera CJ; Lees JG; Tonkin RS; Makker PGS; Carrive P; Butovsky O; Moalem-Taylor G
J Neurosci; 2019 Mar; 39(12):2326-2346. PubMed ID: 30651334
[TBL] [Abstract][Full Text] [Related]
5. Ketamine reduces remifentanil-induced postoperative hyperalgesia mediated by CaMKII-NMDAR in the primary somatosensory cerebral cortex region in mice.
Qi F; Liu T; Zhang X; Gao X; Li Z; Chen L; Lin C; Wang L; Wang ZJ; Tang H; Chen Z
Neuropharmacology; 2020 Jan; 162():107783. PubMed ID: 31541650
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of CaMKIIα in the Central Nucleus of Amygdala Attenuates Fentanyl-Induced Hyperalgesia in Rats.
Li Z; Li C; Yin P; Wang ZJ; Luo F
J Pharmacol Exp Ther; 2016 Oct; 359(1):82-9. PubMed ID: 27451410
[TBL] [Abstract][Full Text] [Related]
7. Silencing of the RNA-binding protein HuR attenuates hyperalgesia and motor disability in experimental autoimmune encephalomyelitis.
Sanna MD; Quattrone A; Galeotti N
Neuropharmacology; 2017 Sep; 123():116-125. PubMed ID: 28599923
[TBL] [Abstract][Full Text] [Related]
8. Establishment and characterization of an optimized mouse model of multiple sclerosis-induced neuropathic pain using behavioral, pharmacologic, histologic and immunohistochemical methods.
Khan N; Woodruff TM; Smith MT
Pharmacol Biochem Behav; 2014 Nov; 126():13-27. PubMed ID: 25223977
[TBL] [Abstract][Full Text] [Related]
9. Inosine, an Endogenous Purine Nucleoside, Suppresses Immune Responses and Protects Mice from Experimental Autoimmune Encephalomyelitis: a Role for A2A Adenosine Receptor.
Junqueira SC; Dos Santos Coelho I; Lieberknecht V; Cunha MP; Calixto JB; Rodrigues ALS; Santos ARS; Dutra RC
Mol Neurobiol; 2017 Jul; 54(5):3271-3285. PubMed ID: 27130268
[TBL] [Abstract][Full Text] [Related]
10. Reversal of chronic inflammatory pain by acute inhibition of Ca2+/calmodulin-dependent protein kinase II.
Luo F; Yang C; Chen Y; Shukla P; Tang L; Wang LX; Wang ZJ
J Pharmacol Exp Ther; 2008 Apr; 325(1):267-75. PubMed ID: 18178903
[TBL] [Abstract][Full Text] [Related]
11. The role of kinin B1 and B2 receptors in the persistent pain induced by experimental autoimmune encephalomyelitis (EAE) in mice: evidence for the involvement of astrocytes.
Dutra RC; Bento AF; Leite DF; Manjavachi MN; Marcon R; Bicca MA; Pesquero JB; Calixto JB
Neurobiol Dis; 2013 Jun; 54():82-93. PubMed ID: 23454198
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive catwalk gait analysis in a chronic model of multiple sclerosis subjected to treadmill exercise training.
Bernardes D; Oliveira ALR
BMC Neurol; 2017 Aug; 17(1):160. PubMed ID: 28830377
[TBL] [Abstract][Full Text] [Related]
13. Secondary hyperalgesia in the postoperative pain model is dependent on spinal calcium/calmodulin-dependent protein kinase II alpha activation.
Jones TL; Lustig AC; Sorkin LS
Anesth Analg; 2007 Dec; 105(6):1650-6, table of contents. PubMed ID: 18042863
[TBL] [Abstract][Full Text] [Related]
14. Tissue Transglutaminase contributes to experimental multiple sclerosis pathogenesis and clinical outcome by promoting macrophage migration.
van Strien ME; de Vries HE; Chrobok NL; Bol JGJM; Breve JJP; van der Pol SMP; Kooij G; van Buul JD; Karpuj M; Steinman L; Wilhelmus MM; Sestito C; Drukarch B; Van Dam AM
Brain Behav Immun; 2015 Nov; 50():141-154. PubMed ID: 26133787
[TBL] [Abstract][Full Text] [Related]
15. Wnt signaling in the pathogenesis of multiple sclerosis-associated chronic pain.
Yuan S; Shi Y; Tang SJ
J Neuroimmune Pharmacol; 2012 Dec; 7(4):904-13. PubMed ID: 22547300
[TBL] [Abstract][Full Text] [Related]
16. CaMKIIα may modulate fentanyl-induced hyperalgesia via a CeLC-PAG-RVM-spinal cord descending facilitative pain pathway in rats.
Li Z; Yin P; Chen J; Jin S; Liu J; Luo F
PLoS One; 2017; 12(5):e0177412. PubMed ID: 28489932
[TBL] [Abstract][Full Text] [Related]
17. Altered excitatory-inhibitory balance within somatosensory cortex is associated with enhanced plasticity and pain sensitivity in a mouse model of multiple sclerosis.
Potter LE; Paylor JW; Suh JS; Tenorio G; Caliaperumal J; Colbourne F; Baker G; Winship I; Kerr BJ
J Neuroinflammation; 2016 Jun; 13(1):142. PubMed ID: 27282914
[TBL] [Abstract][Full Text] [Related]
18. Anti-IL-6 receptor antibody improves pain symptoms in mice with experimental autoimmune encephalomyelitis.
Serizawa K; Tomizawa-Shinohara H; Magi M; Yogo K; Matsumoto Y
J Neuroimmunol; 2018 Jun; 319():71-79. PubMed ID: 29685293
[TBL] [Abstract][Full Text] [Related]
19. Neuropathic pain behaviours in a chronic-relapsing model of experimental autoimmune encephalomyelitis (EAE).
Olechowski CJ; Truong JJ; Kerr BJ
Pain; 2009 Jan; 141(1-2):156-64. PubMed ID: 19084337
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological inhibition of the NLRP3 inflammasome as a potential target for multiple sclerosis induced central neuropathic pain.
Khan N; Kuo A; Brockman DA; Cooper MA; Smith MT
Inflammopharmacology; 2018 Feb; 26(1):77-86. PubMed ID: 28965161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
